Search hospitals > Illinois > Chicago
Rush University Medical Center
Claim this profileChicago, Illinois 60612
Global Leader in Cancer
Global Leader in Lymphoma
Conducts research for Syndrome
Conducts research for Breast Cancer
Conducts research for Human Immunodeficiency Virus Infection
1654 reported clinical trials
119 medical researchers
Summary
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Lymphoma, Syndrome, Breast Cancer, Human Immunodeficiency Virus Infection and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,403 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and Brian Cole, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Lymphoma
Global LeaderMYC positive
BCL2 positive
CD20 positive
Top PIs
Alan TanRush University Medical Center4 years of reported clinical research
Studies Cancer
Studies Renal Cell Carcinoma
14 reported clinical trials
25 drugs studied
Dian Wang, MD, PhDRush University Medical Center7 years of reported clinical research
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
12 reported clinical trials
36 drugs studied
Timothy M Kuzel, MDRush University Medical Center7 years of reported clinical research
Studies Melanoma
Studies Lymphoma
10 reported clinical trials
35 drugs studied
Brian Cole, MDRush University Medical Center5 years of reported clinical research
Studies Rotator Cuff Injury
Studies Rotator Cuff Tears
10 reported clinical trials
20 drugs studied
Clinical Trials running at Rush University Medical Center
Prostate Cancer
Breast Cancer
Lung Cancer
Small Cell Lung Cancer
Cancer
Anal Cancer
Non-Small Cell Lung Cancer
Anal Squamous Cell Carcinoma
Renal Cell Carcinoma
Ovarian Tumors
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rush University Medical Center?
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Lymphoma, Syndrome, Breast Cancer, Human Immunodeficiency Virus Infection and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,403 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and Brian Cole, MD.
Where is Rush University Medical Center located?
Rush University Medical Center is conveniently situated at 1620 W. Harrison St., Chicago, IL 60612, easily accessible from the Eisenhower Expressway (I-290) and just five minutes west of Chicago's Loop. Public transportation options include two nearby Chicago Transit Authority (CTA) train stations: Illinois Medical District (Blue Line) and Polk (Pink Line). Additionally, the area is served by several CTA bus routes: #7 Harrison, #9 Ashland, #126 Jackson, and #157 Streeterville/Taylor.
Who should I call to ask about financial aid or insurance network?
**Rush University Medical Center Financial Assistance and Insurance Information:**
- **Financial Assistance:** Contact at (312) 942-5693 or (866) 761-7812, or email billing_info@rush.edu. Office hours are Monday through Friday, 8 a.m. to 4:30 p.m.
- **Insurance Inquiries:** Contact the Insurance Department at (630) 978-2532 or visit [www.vnahealth.com](http://www.vnahealth.com). Address: VNA Health Center, 400 N. Highland Ave., Aurora, IL 60506.
What insurance does Rush University Medical Center accept?
Rush University Medical Center accepts a wide range of insurance plans, including HMO, POS, and PPO. RUSH Copley Medical Group specifically accepts commercial and governmental plans such as Aetna, Blue Cross/Blue Shield, Cigna, Humana, Medicare Part B, Medicare Advantage, Tricare, and United Healthcare. Short-term health insurance plans with PPO networks like Aetna or Cigna also typically provide coverage at Rush.
What awards or recognition has Rush University Medical Center received?
Rush University Medical Center, located in Chicago, Illinois, is renowned for its exceptional research and care. It has been designated as a Center of Excellence for Parkinson's Disease Program by the Parkinson's Foundation and a National Pancreas Foundation Center of Excellence for Pancreatic Cancer. The hospital also boasts accreditations from prestigious organizations including the American College of Surgeons' Commission on Cancer, the Foundation for the Accreditation of Cellular Therapy, and the American College of Radiology, highlighting its dedication to high-quality care and patient safety.